These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33001536)

  • 1. Patients with highly unstable type 1 diabetes eligible for islet transplantation can be managed with a closed-loop insulin delivery system: A series of N-of-1 randomized controlled trials.
    Benhamou PY; Lablanche S; Vambergue A; Doron M; Franc S; Charpentier G
    Diabetes Obes Metab; 2021 Jan; 23(1):186-194. PubMed ID: 33001536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beneficial effects of closed-loop insulin delivery in patients with highly unstable type 1 diabetes eligible for islet transplantation are maintained over 6 months: An extension study of the DBLHU-WP10 trial.
    Benhamou PY; Lablanche S; Vambergue A; Pou S; Madrolle S; Romero-Ugalde H; Franc S; Charpentier G
    Diabetes Obes Metab; 2022 May; 24(5):956-961. PubMed ID: 35099098
    [No Abstract]   [Full Text] [Related]  

  • 3. Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial.
    Wilson LM; Jacobs PG; Ramsey KL; Resalat N; Reddy R; Branigan D; Leitschuh J; Gabo V; Guillot F; Senf B; El Youssef J; Steineck IIK; Tyler NS; Castle JR
    Diabetes Care; 2020 Nov; 43(11):2721-2729. PubMed ID: 32907828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.
    Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW
    Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective analysis of satisfaction and usability of closed-loop Diabeloop DBLHU treatment in patients with highly unstable type 1 diabetes.
    Delagenière J; Schwartz C; Doron M; Huneker E; Franc S; Charpentier G; Vambergue A; Benhamou PY; Lablanche S
    Acta Diabetol; 2021 Dec; 58(12):1709-1711. PubMed ID: 34272606
    [No Abstract]   [Full Text] [Related]  

  • 6. Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6-12 years: a randomised, controlled, cross-over, non-inferiority trial.
    Kariyawasam D; Morin C; Casteels K; Le Tallec C; Sfez A; Godot C; Huneker E; Garrec N; Benhamou PY; Polak M; Charpentier G; Franc S; Beltrand J
    Lancet Digit Health; 2022 Mar; 4(3):e158-e168. PubMed ID: 35216750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared with low glucose suspend: a crossover RCT.
    Benhalima K; van Nes F; Laenen A; Gillard P; Mathieu C
    Diabetologia; 2021 Dec; 64(12):2725-2730. PubMed ID: 34647140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower versus standard sucrose dose for treating hypoglycemia in patients with type 1 diabetes mellitus in therapy with predictive low glucose suspend (PLGS) augmented insulin pumps: A randomized crossover trial in Santiago, Chile.
    Grassi B; Onetto MT; Zapata Y; Jofré P; Echeverría G
    Diabetes Metab Syndr; 2021; 15(3):695-701. PubMed ID: 33813244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No more hypoglycaemia on days with physical activity and unrestricted diet when using a closed-loop system for 12 weeks: A post hoc secondary analysis of the multicentre, randomized controlled Diabeloop WP7 trial.
    Franc S; Benhamou PY; Borot S; Chaillous L; Delemer B; Doron M; Guerci B; Hanaire H; Huneker E; Jeandidier N; Amadou C; Renard E; Reznik Y; Schaepelynck P; Simon C; Thivolet C; Thomas C; Hannaert P; Charpentier G
    Diabetes Obes Metab; 2021 Sep; 23(9):2170-2176. PubMed ID: 34009725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does fully closed-loop automated insulin delivery improve glycaemic control in patients with type 2 diabetes? A meta-analysis of randomized controlled trials.
    Amer BE; Yaqout YE; Abozaid AM; Afifi E; Aboelkhier MM
    Diabet Med; 2024 Jan; 41(1):e15196. PubMed ID: 37567739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the Diabeloop closed-loop system to improve glycaemic control in patients with type 1 diabetes exposed to gastronomic dinners or to sustained physical exercise.
    Hanaire H; Franc S; Borot S; Penfornis A; Benhamou PY; Schaepelynck P; Renard E; Guerci B; Jeandidier N; Simon C; Hannaert P; Xhaard I; Doron M; Huneker E; Charpentier G; Reznik Y
    Diabetes Obes Metab; 2020 Mar; 22(3):324-334. PubMed ID: 31621186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial.
    Brown SA; Beck RW; Raghinaru D; Buckingham BA; Laffel LM; Wadwa RP; Kudva YC; Levy CJ; Pinsker JE; Dassau E; Doyle FJ; Ambler-Osborn L; Anderson SM; Church MM; Ekhlaspour L; Forlenza GP; Levister C; Simha V; Breton MD; Kollman C; Lum JW; Kovatchev BP;
    Diabetes Care; 2020 Aug; 43(8):1822-1828. PubMed ID: 32471910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated Insulin Delivery with SGLT2i Combination Therapy in Type 1 Diabetes.
    Garcia-Tirado J; Farhy L; Nass R; Kollar L; Clancy-Oliveri M; Basu R; Kovatchev B; Basu A
    Diabetes Technol Ther; 2022 Jul; 24(7):461-470. PubMed ID: 35255229
    [No Abstract]   [Full Text] [Related]  

  • 15. Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial.
    Stewart ZA; Wilinska ME; Hartnell S; O'Neil LK; Rayman G; Scott EM; Barnard K; Farrington C; Hovorka R; Murphy HR
    Diabetes Care; 2018 Jul; 41(7):1391-1399. PubMed ID: 29535135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How does a predictive low glucose suspend (PLGS) system tackle pediatric lifespan challenges in diabetes treatment? Real world data analysis.
    Gaweł WB; Deja G; Kamińska H; Tabor A; Skała-Zamorowska E; Jarosz-Chobot P
    Pediatr Diabetes; 2020 Mar; 21(2):280-287. PubMed ID: 31715059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial.
    Abitbol A; Rabasa-Lhoret R; Messier V; Legault L; Smaoui M; Cohen N; Haidar A
    Diabetes Technol Ther; 2018 Mar; 20(3):189-196. PubMed ID: 29393675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes.
    Spaic T; Driscoll M; Raghinaru D; Buckingham BA; Wilson DM; Clinton P; Chase HP; Maahs DM; Forlenza GP; Jost E; Hramiak I; Paul T; Bequette BW; Cameron F; Beck RW; Kollman C; Lum JW; Ly TT;
    Diabetes Care; 2017 Mar; 40(3):359-366. PubMed ID: 28100606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
    Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
    Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing Hypoglycemia in the Real World: A Retrospective Analysis of Predictive Low-Glucose Suspend Technology in an Ambulatory Insulin-Dependent Cohort.
    Müller L; Habif S; Leas S; Aronoff-Spencer E
    Diabetes Technol Ther; 2019 Sep; 21(9):478-484. PubMed ID: 31329468
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.